TBG Diagnostics Ltd TDLAF:OTCQB

RT Quote | Exchange | USD
Last | 05/14/21 EDT
0.06quote price arrow down-0.0088 (-12.7907%)
Volume
12,000
52 week range
0.01 - 0.22

...

Loading . . .
  • Open0.0436
  • Day High0.06
  • Day Low0.0436
  • Prev Close0.0688
  • 52 Week High0.22
  • 52 Week High Date07/08/20
  • 52 Week Low0.01
  • 52 Week Low Date05/03/21

Key Stats

  • Market Cap13.06M
  • Shares Out217.59M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.02
  • YTD % Change-17.3

KEY STATS

  • Open0.0436
  • Day High0.06
  • Day Low0.0436
  • Prev Close0.0688
  • 52 Week High0.22
  • 52 Week High Date07/08/20
  • 52 Week Low0.01
  • 52 Week Low Date05/03/21
  • Market Cap13.06M
  • Shares Out217.59M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.02
  • YTD % Change-17.3

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-4.77
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-1.634M
  • ROE (MRQ)-38.05%
  • Revenue (MRQ)3.58M
  • Gross Margin (MRQ)57.95%
  • Net Margin (MRQ)-76.57%
  • Debt To Equity (MRQ)74.38%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On TBG Diagnostics Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
TBG Diagnostics Limited, formerly Progen Pharmaceuticals Limited, is a biotechnology company. The Company's principal activities include the discovery, research and development of pharmaceutical therapeutics for the treatment of human diseases, and the provision of contract services related to the process development, manufacture and quality assurance of biopharmaceutical products. The Company's segments include Research & Development, and Manufacturing. The Company is...
Indrajit Arulampalam
Chairman
Willy Hsu
Chief Operating Officer
Address
U 6 138 Juliette Street, Greenslopes
Brisbane, QLD
4120
Australia